Two Sigma Investments, LP Gossamer Bio, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 630,961 shares of GOSS stock, worth $624,651. This represents 0.0% of its overall portfolio holdings.

Number of Shares
630,961
Previous 309,979 103.55%
Holding current value
$624,651
Previous $278,000 124.46%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.79 - $1.25 $253,575 - $401,227
320,982 Added 103.55%
630,961 $624,000
Q2 2024

Aug 14, 2024
SELL
$0.51 - $1.27 $254,383 - $633,465
-498,792 Reduced 61.67%
309,979 $278,000
Q1 2024

May 15, 2024
SELL
$0.8 - $1.51 $170,792 - $322,369
-213,490 Reduced 20.88%
808,771 $954,000
Q4 2023

Feb 14, 2024
BUY
$0.48 - $1.08 $233,359 - $525,059
486,166 Added 90.69%
1,022,261 $930,000
Q3 2023

Nov 14, 2023
SELL
$0.78 - $1.82 $805,952 - $1.88 Million
-1,033,273 Reduced 65.84%
536,095 $444,000
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.53 $299,831 - $468,105
-305,951 Reduced 16.31%
1,569,368 $1.88 Million
Q1 2023

May 15, 2023
BUY
$0.96 - $2.92 $395,711 - $1.2 Million
412,199 Added 28.17%
1,875,319 $2.36 Million
Q4 2022

Feb 14, 2023
BUY
$1.74 - $12.87 $935,063 - $6.92 Million
537,393 Added 58.05%
1,463,120 $3.17 Million
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $4.9 Million - $10.1 Million
680,167 Added 276.99%
925,727 $11.1 Million
Q2 2022

Aug 15, 2022
SELL
$5.97 - $9.97 $1.21 Million - $2.03 Million
-203,497 Reduced 45.32%
245,560 $2.06 Million
Q1 2022

May 16, 2022
BUY
$8.44 - $12.49 $985,842 - $1.46 Million
116,806 Added 35.16%
449,057 $3.9 Million
Q4 2021

Feb 14, 2022
BUY
$10.12 - $14.07 $1.45 Million - $2.01 Million
142,891 Added 75.46%
332,251 $3.76 Million
Q3 2021

Nov 15, 2021
SELL
$7.25 - $13.23 $2.09 Million - $3.82 Million
-288,700 Reduced 60.39%
189,360 $2.38 Million
Q2 2021

Aug 16, 2021
SELL
$8.0 - $9.75 $1.76 Million - $2.15 Million
-220,015 Reduced 31.52%
478,060 $3.88 Million
Q1 2021

May 17, 2021
BUY
$8.63 - $10.94 $4.57 Million - $5.79 Million
529,220 Added 313.42%
698,075 $6.46 Million
Q4 2020

Feb 16, 2021
SELL
$8.3 - $13.59 $1.57 Million - $2.56 Million
-188,708 Reduced 52.78%
168,855 $1.63 Million
Q3 2020

Nov 16, 2020
BUY
$11.3 - $14.75 $729,347 - $952,024
64,544 Added 22.03%
357,563 $4.44 Million
Q2 2020

Aug 14, 2020
BUY
$9.52 - $15.98 $2.53 Million - $4.24 Million
265,553 Added 966.84%
293,019 $3.81 Million
Q1 2020

May 15, 2020
BUY
$8.0 - $15.48 $219,728 - $425,173
27,466 New
27,466 $279,000

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $93M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email